<?xml version="1.0" encoding="UTF-8"?>
<p>Previous studies indicate that the inhibition of COX-2 resulted in an overall 70% reduction in cancer risk for breast, lung, prostate and, colon cancers, and also in cancers whose etiology is associated with several mutagenic conditions such as tobacco, alcohol, UV light, oxidative stress, and infections by viruses or bacteria [
 <xref rid="B120-ijms-22-00265" ref-type="bibr">120</xref>,
 <xref rid="B121-ijms-22-00265" ref-type="bibr">121</xref>]. 
</p>
